Eurofins U.S. Clinical Diagnostic Laboratories Partner with Insurance Providers to Cover FDA-Authorized At-Home COVID-19 Test
Eurofins announces that its FDA-authorized At-Home COVID-19 Nasal PCR Test is now being covered by Medicare, Medicaid and commercial insurance providers. The Emergency Use Authorization ("EUA") authorized self-collection kit gives consumers a minimally invasive, convenient and quick option to test from the comfort of their home. Results are provided via email link within 24 hours of sample receipt.
ESPN - Inside the complex choreography of COVID-19 testing that keeps tournaments running
The vials are ready to leave at 2:30 p.m. from Portland, Oregon. It's mid-September, five days before the Cambia Portland Classic LPGA tournament begins, and a highly choreographed maneuver, as complex as anything else in the tournament, is about to take place. The vials containing oral or nasal swab samples from players, are part of a big goal: to get LPGA athletes tested for COVID-19 in record time so they can be cleared for each tournament.
Viracor Launches Combined Test for COVID-19, Influenza and RSV as the Flu Season Approaches
With flu season underway and US COVID-19 cases reaching 10 million, these combined tests will play an important role for extended care facilities, employers, schools, and healthcare systems by distinguishing between multiple respiratory pathogens that exhibit overlapping symptoms including COVID-19 and Flu.
NPR Kansas City - Lee’s Summit Lab Develops COVID-19 Test You Can Administer At Home
The at-home test has come on the market as a third surge of coronavirus infections has spread across the country.
The Food and Drug Administration has granted emergency use authorization to Viracor Eurofins, a clinical diagnostics lab in Lee’s Summit, Missouri, for an at-home, self-administered COVID-19 test.
The process is simple and uses a nasal swab that looks like a Q-tip to rub the inside of each nostril three times. The sample is then sent to a Viracor lab, which emails the results within 24 hours of receipt.
Kansas City Business Journal - Lee’s Summit’s Viracor Eurofins develops at-home Covid-19 test kit
Lee's Summit-based Viracor Eurofins has developed an at-home Covid-19 test kit that now has received emergency-use authorization from the Food and Drug Administration.
Viracor's nasal test is less invasive than others on the market, and the swab is similar to a Q-tip, Viracor President Dr. Michelle Altrich told the Kansas City Business Journal.
The Kansas City Star - Viracor Launches COVID-19 At-Home Test Kit
The at-home test, created by Viracor Eurofins, can be ordered online for $89. Viracor says patients will get results within 24 hours — no more than 48 hours — from the time it receives the sample.
You collect the sample yourself from your nose, rubbing a swab inside both nostrils. The test’s developers say it’s more comfortable than that COVID-19 test you might have had at the doctor’s office or community testing site.
Mass Device - FDA Issues EUA for Viracor Eurofins' At-Home COVID-19 Test
Luxembourg-based Eurofins’ at-home nasal PCR test is touted as a minimally invasive and quick option that offers results via email within 24 hours of sample receipt. The test is available through Eurofins’ direct-to-consumer company, EmpowerDX, and is offered online for $89.
The test was developed based on Eurofins’ previously authorized SARS-CoV-2 RT-PCR assay, which received EUA back in March. The company has ramped up its U.S. testing capacity to over 500,000 samples per week with a turnaround time averaging less than 18 hours.
Eurofins U.S. Clinical Diagnostics Network Receives EUA Approval of At Home COVID-19 Test
Viracor has received EUA from the U.S. Food and Drug Administration (FDA) for their At-Home COVID-19 Nasal PCR Test. The EUA authorized self-collection kit gives consumers a minimally invasive, convenient and quick option to test from the comfort of their home. Results are provided via email within 24 hours of sample receipt.
Invicta FC Partners with Global Laboratory Testing Provider, Eurofins, to Bolster Athlete Safety During COVID-19 Pandemic
Since the start of the COVID-19 pandemic, all Invicta FC events have featured testing for athletes, corners, Invicta FC staff and commission officials. Now, leveraging Eurofins’ SAFER@WORK™ protocols, the world’s leading combat sports organization for women has ensured that future events will continue to be a safe environment for all participants.